Showing 1 - 20 results of 122 for search 'T V Korotaeva', query time: 0.03s Refine Results
  1. 1
    PROSPECTS FOR USING INTERLEUKIN-17 INHIBITORS, A NEW CLASS OF DRUGS FOR TARGETED THERAPY OF PSORIATIC ARTHRITIS

    PROSPECTS FOR USING INTERLEUKIN-17 INHIBITORS, A NEW CLASS OF DRUGS FOR TARGETED THERAPY OF PSORIATIC ARTHRITIS by T. V. Korotaeva

    Published 2016-07-01
    Get full text
    Article
  2. 2
    Immunogenicity induced by biologicals in the treatment of psoriasis and psoriatic arthritis: View of the problem

    Immunogenicity induced by biologicals in the treatment of psoriasis and psoriatic arthritis: View of the problem by T. V. Korotaeva

    Published 2016-01-01
    Get full text
    Article
  3. 3
    RESULTS OF EVALUATING THE EFFICACY OF SECUKINUMAB VERSUS ADALIMUMAB IN TREATING PSORIATIC ARTHRITIS BY USING THE MATCHING-ADJUSTED INDIRECT COMPARISON METHOD

    RESULTS OF EVALUATING THE EFFICACY OF SECUKINUMAB VERSUS ADALIMUMAB IN TREATING PSORIATIC ARTHRITIS BY USING THE MATCHING-ADJUSTED INDIRECT COMPARISON METHOD by T. V. Korotaeva

    Published 2016-12-01
    Get full text
    Article
  4. 4
    Results of direct comparison of the clinical efficacy of ixekizumab and adalimumab: data from the SPIRIT H2H study

    Results of direct comparison of the clinical efficacy of ixekizumab and adalimumab: data from the SPIRIT H2H study by T. V. Korotaeva

    Published 2020-09-01
    Get full text
    Article
  5. 5
    Sovremennye vozmozhnosti terapii psoriaticheskogo artrita

    Sovremennye vozmozhnosti terapii psoriaticheskogo artrita by T V Korotaeva

    Published 2008-04-01
    Get full text
    Article
  6. 6
    Etanercept (Enbrel) in the treatment of psoriatic arthritis

    Etanercept (Enbrel) in the treatment of psoriatic arthritis by T V Korotaeva

    Published 2009-12-01
    Get full text
    Article
  7. 7
    PSORIATIC ARTHRITIS: CLASSIFICATION, CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT

    PSORIATIC ARTHRITIS: CLASSIFICATION, CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT by T. V. Korotaeva

    Published 2014-12-01
    Get full text
    Article
  8. 8
    Inhibitors of interleukin 17A in the treatment of psoriatic arthritis: what's new?

    Inhibitors of interleukin 17A in the treatment of psoriatic arthritis: what's new? by Т. V. Korotaeva

    Published 2021-04-01
    Get full text
    Article
  9. 9
    Angiogenesis in patients with psoriasis and psoriatic arthritis: cell-mediated and humoral mechanisms, its role in pathogenesis, and searching for promising therapeutic targets

    Angiogenesis in patients with psoriasis and psoriatic arthritis: cell-mediated and humoral mechanisms, its role in pathogenesis, and searching for promising therapeutic targets by T.V. Korotaeva

    Published 2014-05-01
    Get full text
    Article
  10. 10
    Medical and social care program for patients with psoriasis and/or psoriatic arthritis eligible for biological dmards in real clinical practice

    Medical and social care program for patients with psoriasis and/or psoriatic arthritis eligible for biological dmards in real clinical practice by L. S. Kruglova, T. V. Korotaeva

    Published 2020-11-01
    Get full text
    Article
  11. 11
    Dactylitis in psoriatic arthritis: clinical features, diagnosis, immunopathogenesis, and treatment

    Dactylitis in psoriatic arthritis: clinical features, diagnosis, immunopathogenesis, and treatment by T. V. Korotaeva, E. Yu. Loginova

    Published 2018-04-01
    Get full text
    Article
  12. 12
    Results of studying the clinical efficacy and safety of tofacitinib in the treatment of psoriatic arthritis

    Results of studying the clinical efficacy and safety of tofacitinib in the treatment of psoriatic arthritis by T. V. Korotaeva, E. Yu. Loginova

    Published 2019-05-01
    Get full text
    Article
  13. 13
    Standards of therapy of psoriatic arthritis

    Standards of therapy of psoriatic arthritis by T V Korotaeva, E L Nasonov

    Published 2009-06-01
    Get full text
    Article
  14. 14
    Early psoriatic arthritis

    Early psoriatic arthritis by E. Y. Loginova, T. V. Korotaeva

    Published 2008-12-01
    Get full text
    Article
  15. 15
    LIVER DAMAGE IN PSORIASIS AND PSORIATIC ARTHRITIS: A LITERATURE REVIEW

    LIVER DAMAGE IN PSORIASIS AND PSORIATIC ARTHRITIS: A LITERATURE REVIEW by Yu. L. Korsakova, T. V. Korotaeva

    Published 2017-09-01
    Get full text
    Article
  16. 16
    Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis

    Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis by Yu. L. Korsakova, T. V. Korotaeva

    Published 2018-07-01
    Get full text
    Article
  17. 17
    Immunopathogenetic mechanisms of action of ustekinumab, a new drug for the treatment of psoriatic arthritis and psoriasis

    Immunopathogenetic mechanisms of action of ustekinumab, a new drug for the treatment of psoriatic arthritis and psoriasis by T. V. Korotaeva, E. Yu. Loginova

    Published 2015-06-01
    Get full text
    Article
  18. 18
    Modern pharmacotherapy of psoriatic arthritis

    Modern pharmacotherapy of psoriatic arthritis by Yu. L. Korsakova, T. V. Korotaeva

    Published 2019-03-01
    Get full text
    Article
  19. 19
    Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology

    Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology by E. L. Nasonov, T. V. Korotaeva

    Published 2022-05-01
    Get full text
    Article
  20. 20
    Clinical experience with apremilast for psoriatic arthritis

    Clinical experience with apremilast for psoriatic arthritis by E. Yu. Loginova, T. V. Korotaeva

    Published 2018-09-01
    Get full text
    Article

Search Tools: